TPH2 and drug-induced dyskinesia: Carriers of at least one TPH2 rs4290270 A allele and at least one 5-HTTLPR S variant had lower odds for development of dyskinesia (OR = 0.29; 95% CI = 0.09–0.91; p = 0.034).